Search

Your search keyword '"Korobelnik, Jean-François"' showing total 41 results

Search Constraints

Start Over You searched for: Author "Korobelnik, Jean-François" Remove constraint Author: "Korobelnik, Jean-François" Publisher elsevier bv Remove constraint Publisher: elsevier bv
41 results on '"Korobelnik, Jean-François"'

Search Results

2. Faricimab Treat-and-Extend for Diabetic Macular Edema

3. Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial

4. Association of long-term exposure to ambient air pollution with retinal neurodegeneration: the prospective Alienor study

9. Physical Activity, Incidence, and Progression of Age-Related Macular Degeneration: A Multicohort Study

10. TENAYA and LUCERNE

12. Predicting Progression to Advanced Age-Related Macular Degeneration from Clinical, Genetic, and Lifestyle Factors Using Machine Learning

13. Previous dramatic reduction of HbA1c and retinopathy in Type 2 Diabetes

14. Mediterranean Diet and Incidence of Advanced Age-Related Macular Degeneration: The EYE-RISK Consortium

15. Ocular injuries caused by less-lethal weapons in France

18. Increased High-Density Lipoprotein Levels Associated with Age-Related Macular Degeneration

19. Mediterranean Diet and Incidence of Advanced Age-Related Macular Degeneration

20. Systemic and Ocular Determinants of Peripapillary Retinal Nerve Fiber Layer Thickness Measurements in the European Eye Epidemiology (E3) Population

21. The Decreasing Prevalence of Nonrefractive Visual Impairment in Older Europeans

22. Adapted Surgical Procedure for Argus II Retinal Implantation: Feasibility, Safety, Efficiency, and Postoperative Anatomic Findings

23. Prevalence of Age-Related Macular Degeneration in Europe

24. Skin autofluorescence, renal insufficiency and retinopathy in patients with type 2 diabetes

26. Intravitreal Aflibercept for Diabetic Macular Edema

27. Scheduled versus Pro Re Nata Dosing in the VIEW Trials

28. Intravitreal Aflibercept for Diabetic Macular Edema

29. Endophthalmitis After Intravitreal Injections: Incidence, Presentation, Management, and Visual Outcome

30. Increasing Prevalence of Myopia in Europe and the Impact of Education

31. Reply

32. Intravitreal Aflibercept for Diabetic Macular Edema

33. Intravitreal Aflibercept for Macular Edema Secondary to Central Retinal Vein Occlusion: 18-Month Results of the Phase 3 GALILEO Study

34. Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration

35. Intravitreal Aflibercept Injection for Macular Edema Resulting from Central Retinal Vein Occlusion

36. High Concentrations of Plasma n3 Fatty Acids Are Associated with Decreased Risk for Late Age-Related Macular Degeneration

38. Efficacy and Safety of Monthly versus Quarterly Ranibizumab Treatment in Neovascular Age-related Macular Degeneration: The EXCITE Study

Catalog

Books, media, physical & digital resources